INTRODUCTION
The major ~ffects of anaesthesia and surgery on renal functlOn and body fluid relocation have been assumed to be due to indirect circulatory and neuroendocrine responses. In addition, recent studies have demonstrated that anaesthetic agents also have direct effects on renal function, as exemplified by the delayed toxicity seen following methoxyflurane anaesthesia. This review will discuss the combined effects of anaesthesia and surgery upon renal function and fluid-electrolyte homeostasis in normal man, anaesthetic problems of patients with renal disease having been described in recent reviews (Vandam et al. 1962 , Jacobsen et al. 1968 , Prescott 1972 , Slawson 1972 , Mazze and Cousins 1973b . Mention will also be made of renal effects of drug interactions which may occur between anaesthetics and therapeutic agents such as enzyme-inducing drugs and antibiotics.
IMMEDIATE EFFECTS OF ANAESTHETICS ON
RENAL FUNCTION The earliest reports of the effects of anaesthesia on renal function are from Pringle et al. (1905) . They reported the effects of ether anaesthesia on water and non-protein nitrogen excretion in eight patients undergoing a variety of minor and major surgical procedures. Urine flow averaged 50 ml/hour on the day prior to surgery, fell to 1·2 ml/hour during the operation, and returned toward normal post-operatively. It was noted that patients with the smallest post-operative urine output vomited the most and received the smallest quantities of fluids on the day of surgery. In surgical patients without renal disease, all general anaesthetic agents temporarily depress renal function: urine flow, glomerular filtration rate (GFR), renal blood flow (RBF), and electrolyte excretion are reduced. This consistent and generalized depression of renal function can be attributed to many factors, including the type and duration of surgical procedure; the physical status of the patient, especially that of the cardiovascular and renal systems (Hayes and Goldenberg 1963, Seitzman et al. 1963 ), pre-operative and intra-operative blood volume, fluid and electrolyte balance (Boba and Landmesser 1961 , Hutchin et al. 1961 , Mazze and Barry 1967 ; the choice of anaesthetic agent (Deutsch et al. 1966b ) and the depth of anaesthesia (Mazze et al. 1963 , Barry et al. 1964 , Blackmore et al. 1960 . Changes in renal function following spinal and epidural anaesthesia (Kennedy et al. 1969 ) tend to parallel the degree of sympathetic blockade and therefore the amount of hypotension produced. In most cases the changes in renal function associated with anaesthesia and surgery are reversible. At the termination of short uncomplicated procedures RBF and GFR usually return to normal within a few hours. When surgery is more extensive and anaesthesia prolonged, secondary effects related to the endocrine system may be manifested by impairment of the ability to promptly excrete a waterload (Hayes and Goldenberg 1963) or inability to elaborate a concentrated urine (Crandell et al. 1966, Cousins and .
The depression in renal function caused by anaesthetic agents may be due to their direct or indirect effects.
In man, the indirect effects on the circulatory, sympathetic nervous, and endocrine systems are generally thought to be most important. However, methoxyflurane causes direct depression of renal tubular function, probably due to inhibition of sodium transport (Mazze et al. 1973b , Anderson 1972 .
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J. Indirect Cirntlator)' Effects
During general anaesthesia RBF may be depressed as a consequence of renal vasoconstriction, systemic hypotension, or both. Drugs causing the greatest increase in catecholamine excretion, such as cyclopropane and diethyl ether (Price et al. 1959 ) tend to support systemic hlood pressure, but in so doing cause a marked increase in renal vascular resistance, decreased RBF and a marked depression in renal function (Deutsch et al. 1967 ). This catecholamine effect may be accentuated in the presence of hypovolaemia (Xelson et al. 1961) . Halothane and thiopentone, although not causing a catecholamine response, are associated with a moderate increase in renal vascular resistance (Deutsch ct al. 1968 ) as blood is shunted away from the kidney to compensate for hypotension induced by myocardial depression and peripheral vasodilation. Renal blood flow and GFR fall with these agents, but not as much as with anaesthetic agents that stimulate catecholamine release.
Present evidence suggests that circulating catecholamines mav cause a redistribution of renal blood flow with a marked reduction occurring in cortical perfusion (Truniger 1971) . Redistribution was prevented by IX-adrenergic blockade, but not bv denervation of the kidney or by prophylactic administration of mannitoL Thus it is possible that administration of anaesthetic drugs with alpha adrenergic blocking activity, such as droperidol, may result in the smallest changes in renal haemodynamics (Gorman and Craythorne 1966) .
The mean blood pressure at which marked reduction of RBF occurs has never been precisely determined in man. Studies in dogs show a reduction in RBF with changes in distribution of cortical blood flow at a mean pressure of 70 mm Hg (Rosen et al. 1967 , Rosen et al. 1968 ) during haemorrhagic shock. This obviously represents vasoconstrictive hypotension for the kidney. Cnfortunately, conclusive information is not" available concerning renal blood flow and distribution of flow during vasodilatory hypotension in man such as is produced by ganglion blocking drugs or anaesthetics such as halothane (Miles et al. 1952 , \Vestermark 1969 , Moyer and McConn 1956 .
~. Indirect Sympathetic Nervous System Effects
The blood vessels of the kidney are richly supplied with sympathetic constrictor fibres derived from the T4-Ll spinal cord segments via the coeliac and renal plexus. There is no sympathetic dilator or parasympathetic inner-vation of the kidney. Under a wide variety of normal and abnormal physiologic conditions, RBF is regulated to maintain stability of GFR (Smith ] 939). With increasing stresss, RBF decreases significantly, however, filtration fraction increases, GFR thereby remaining constant, suggesting efferent renal arteriolar constriction. Finally, during severe stress, GFR also decreases. Judged by their depressant effect on RBF and GFR, general anaesthesia, syncope, pain, severe exercise and haemorrhage represent severe stress. It is assumed that the major renal effects of these diverse stimuli are mediated via sympathetic nervous system stimulation.
Evidence for the role of the sympathetic nervous system in the renal effects of anaesthetics was provided by Berne's (1952) experiments in dogs with one normal and one denervated kidney. Prior to induction of pentobarbital or ~hloralose anaesthesia, RBF and GFR of the denervated and normally innervated kidneys were the same. However, following induction of anaesthesia, RBF and GFR on the normally innervated side decreased while no changes were seen on the denervated side. Changes in the normally innervated kidney appear to have been due to increased vasoconstrictor tone caused by anaesthesia. This evidence suggests that spinal or epidural anaesthesia may produce minimal alterations in renal function provided blood pressure is maintained by measures such as infusion of balanced salt solutions. Complete deafferentation of the operative site and prevention of the release of catecholamines and other renal vasoconstrictive substances may also be important factors in preventing redistribution of cortical blood flow (Truniger 1971 ).
Autoregulation appears to be abolished by anaesthesia with the inhalation anaesthetics. For example, decreases in RBF and GFR of 50 per cent or more occur in patients with stable blood pressures above 80 mm Hg (Mazze et al. ] 963, Habif et al. 1951 ). The only evidence of autoregulation under anaesthesia was obtained in animals anaesthetized with pentobarbital or chloralose (Shipley and Study 1951, Ochwadt ] 961).
Indirect Endocrine Effects
Endocrine effects on renal function during anaesthesia are of great importance and are closely tied to the circulatory effects discussed above. Most important in regulating urine volume is the anti-diuretic hormone (ADH). Renin-angiotensin, aldosterone, adrenaline, and noradrenaline also play important roles in electrolyte excretion and regulation of renal blood flow (Atherton 1972) .
(a) ADH.-It is generally assumed that general anaesthetic agents and narcotics such as morphine cause release of ADH and its attendant renal effects; however, this issue is still unresolved.
Supporting this concept, Duke et al. (1951) injected 4-32 [Lg of morphine into the supraoptic nuclei of dogs after water diuresis had been established. The rate of urine flow fell rapidly and the degree and duration of inhibition was proportional to the dose of morphine. There was no change in systemic blood pressure, RBF or GFR. Control injections of the same volume of saline into the supraoptic nuclei produced only a fleeting change in the rate of urine flow. They concluded that the inhibitory action of morphine on urine flow was due to the liberation of ADH. The same investigators injected morphine intravenously into dogs undergoing water diuresis, both before and after section of the supraoptic tracts. Before operation, morphine invariably caused inhibition of the rate of urine flow, whereas there were no changes in urine volume when morphine was administered after section of the supraoptic tracts.
The principal evidence against morphine or general anaesthesia induced ADH response comes from the studies of Bachmann (1955) . He observed that morphine 2·5 mg/kg, ether, and cyclopropane caused an antidiuretic effect both in normal dogs undergoing a water diuresis and in dogs with diabetes insipidus. Although RBF was not measured, it is likely that the changes in urine flow observed in this experiment were due to the renal haemodynamic depressant effects of these agents. In other studies in man, Papper et al. (1957) reported that 5-10 mg of morphine produced a decrease in urine flow during water diuresis. However, the diminution of urine flow was not always accompanied by a significant rise in urine osmolality as one would expect with an ADH response. In most patients, there was a decrease in GFR and in solute excretion; changes that alone or together are sufficient to account for a decrease in the rate of urine flow.
To establish beyond doubt the presence of an ADH effect following the administration of anaesthetics, it would be necessary to demonstrate a decrease in urine flow, a reciprocal ~ncrease in urinary solute excretion, no change m renal haemodynamics and an increase in circulating ADH. Because of the multiple systemic effects of anaesthetics and the difficulty involved in ADH assay, these conditions are not likely to be met. However, in the absence of such evidence, it seems reasonable to assume that ADH and altered renal haemodynamics are together responsible for the decrease in urine flow associated with the administration of narcotics and general anaesthetic agents. From a practical viewpoint it can be stated that the reduction in urine flow rate produced by overnight dehydration and morphine premedication can usually be reversed by the administration of glucose-water or crystaloid solutions preoperatively (Barry et al. 1964) .
Abnormalities in ADH Secretion. (i)" Inappropriate ADH Secretion" (Increased ADH) : I t has been reported that a sustained and inappropriately elevated secretion of ADH may occur following major surgery in elderly patients who received hypotonic fluids (Deutsch et al. 1966a) . Patients developed hyponatraemia and low serum osmolality despite persistent excretion of a hypertonic urine. This was associated with restlessness, disorientation, stupor, or convulsions. Improvement followed restriction of water intake. Inappropriate ADH secretion is most likely to occur in surgical patients with malignancies such as carcinoma of the brain and lung (Bartter and Schwartz 1967) . It is not known if any operative procedure or anaesthetic agent poses a significantly greater risk of the occurrence of this condition.
(ii) Diabetes Insipidus. The elaboration of large volumes of urine despite rising serum osmolality sometimes follows neurosurgical procedures, particularly posterior fossa operations. Unlike diabetes insipidus of renal origin, diabetes insipidus due to neurogenic causes is responsive to exogenous vasopressin (ADH).
(b) Adrenaline and noradrenaline.-Both adrenaline and noradrenaline produce marked renal vasoconstriction, especially of efferent arterioles, with a decrease in RBF and, to a lesser degree, GFR (Jacobsen et al. 1951) . Sodium chloride and potassium excretion are depressed, probably due to the decreased filtered load or to increased reabsorption from the tubules. Antidiuresis may occur following administration of adrenaline and noradrenaline, and Eranko et al. (1953) have suggested that ADH may be responsible. It is difficult to determine how much of the renal effect of anaesthetic agents such as ether and cyclopropane is due to the increase in catecholamines which they provoke and how much to their other systemic effects.
(c) Renin-A ngiotensin.-An additional hormonal pathway capable of affecting renal func-~1rCHAEL J. COl'SINS A~J) RICHARD 1. :\lAZZE tion is the renin-angiotensin system. Control of renin release is complex and is influenced by several factors which are in turn affected by administration of anaesthesia. Sodium content of tubular fluid, catecholamine levels, sympathetic nervous impulses, and intraluminal pressure of afferent arterioles arc probabl~· all involved (Vander 1967 , Atherton 1972 . Deutsch et al. (1967) have reported increased renin activity in two non-operated subjects anaesthetized with cyclopropane and two with halothane. In contrast, three of four subjects anaesthetized with morphine, thiopental, nitrous oxide and muscle relaxants showed a decrease in renin activity and one showed an increase. The authors suggest that a fall in renin activity might explain the relatively greater reduction in GFR than in RBF observed with this technique in comparison with cyclopropane or halothane. However, the nUITiber of patients is too small and the data too fragmentary for conclusions to be drawn at this time.
(d) Aldostcrolle.--Aldosterone, the hormone responsible for moment to moment control of sodium excretion, is formed in the zona glomerulosa of the adrenal cortex. Its release is primarily dependent upon volume depletion as mediated by baroreceptors in the carotid sinus.
It has been suggested that anaesthetics may change the circulatory pressures which activate the baroreceptors (Rooertson et al. 1956, Price and ""iddicombe 196:!) , may act on the central nervous pathways for the b"aroreceptor reflexes, or on the afferent or efferent limb of the reflex arc, thereby causing aldosterone secretion. It is also possible that anaesthetic agents cause aldosterone release indirectly (a) by affecting circulating angiotensin level; (h) by causing ADH release, which in turn stimulates secretion of ACTH, which then stimulates the zona glomerulosa to liberate aldosterone (Hilton 1960); or (c) by stimulating the sympathetic nervous system thereby causing renal vasoconstriction, leading to renin and angiotensin formation, which in turn stimulates aldosterone formation (Davis 1961) ; or (d) by causing peripheral vasodilation, the expanded vascular compartment stimulating baroreceptors in the same manner as a decrease in blood volume.
Despite anaesthesia induced aldosterone release and the sodium retention it produces, it is well known that serum sodium concentration falls following general anaesthesia and surgery. This dilutional hyponatraemia has been ascribed to dominance of ADH effect, liberation of endogenous sodium-free water from oxidation of fat, and overadministration of sodium-free fluids. Indeed, the post-operative patient has been thought to be intolerant to sodium administration and the practice of infusing small volumes of sodium-free fluid developed (Coller et al. IH44) . The recent reversal of this view is discussed below under" New Concepts of Intraoperati ve Fluid and Electrol\·te Homeostasis ".
Direct Effects of Anaesthetics on Renal Function
Direct effects of anaesthetic agents on renal function are obscured by the marked indirect haemodynamic and endocrine effects considered above. In the isolated toad bladder, cvclopropane and nitrous oxide gave rise to dosedependent stimulation and halothane to dosedependent inhibition of active sodium transport. Ether produced a biphasic response: Initial stimulation followed by inhibition of ion transport (Anderson 1966). These studies suggest that such effects could occur in the renal tubule.
In an effort to elucidate the mechanism of the above responses, Andersen (1967) performed additional experiments in bladders from toads previously-treated with reserpine, alpha and beta adrenergic blocking agents and with epinephrine. Cyclopropane was used as tilt' test gas. In untreated bladders, cyclopropane produced a dose-dependent stimulation of sodium transport, while in reserpinized bladders and those treated with the alpha blockers, cyclopropane produced dose-dependent inhibition of sodium transport. The beta blockers had no effect upon the bladder response to cyclopropane. Andersen concluded that the inhibition of sodium transport by anaesthetic agents may be a direct effect whereas anaesthetic-induced catecholamine release caused a stimulation of sodium transport mediated via alpha receptors. Confirming his earlier studies, Andersen (1972) recently showed that methoxyflurane, a noncatecholamine releasing agent, caused doserelated depression of sodium transport in untreated toad bladders. This effect was graduall\· reversed after discontinuation of the anaesthetic. Table 1 summarizes most of the published reports of changes in renal function observed during general anaesthesia in man. In general, decreases in RBF were greater than those in GFR with a resultant increase in filtration fraction. Urine volume and sodium excretion were always decreased while changes in potassium excretion were variable.
Sli~nIARY OF IM:\IEDIATE EFFECTS OF

AXAESTHETICS ON REKAL FUNCTION
Only the broadest comparisons between studies of the same anaesthetic agent can be made because of variations m premedication, fluid regimens and lack of preCIse information about depth of anaesthesia. The term hydration has caused considerable confusion. For vasoconstrictive hypotension. Also, the balance between minimal depression of GFR and RBF in lightly anaesthetized patients must be weighed against the renal vasoconstrictive effects of catecholamine release due to breakthrough of surgical stimulation. example, in the study of Barry et al. (1964) pre-operative treatment of patients with 10 ml/kg of 1/3 normal saline protected against halothane-induced depression of renal blood flow and glomerular filtration seen in nonhydrated patients anaesthetized with the same agent. Deutsch ct al. (1969) found a lesser, but similar protective effect of hydration with 4 per cent fructose. However, it would be incorrect to compare these two studies, as depth of anaesthesia may not have been the same and hydration with fructose-water is obviously different to infusion of 1/3 normal saline. It is also important to distinguish studies performed during anaesthesia alone from those done during anaesthesia and surgery.
In considering differences between studies the reader should bear in mind the distinction hetween the renal effects of vasodilatory and DIRECT NEPHROTOXICITY The kidney is particularly susceptible to damage from drugs or toxins because of its rich blood supply and increased concentration of excreted compounds in renal tubular cells during reabsorption or secretion. A vascular network serves as a counter-current mechanism resulting in hypertonicity of the interstitium of the renal papillae. Because of this mechanism, medullary concentration of specific compounds is possible to a degree not found in other interstitial tissues of the body. The amount of damage produced by nephrotoxins depends upon many factors such as the duration and intensity of exposure, the degree of toxin binding to plasma protein and tissues other than kidney, the degree and duration of binding to renal tissue, and the rapidity of renal or extra-renal elimination. Toxic damage to the kidney may be either acute or chronic, may predominately affect glomerular or tubular function, or cause generalized renal damage. Toxicity can be manifested by anuria, oliguria or polyuria with urine volume generallv inversely proportional to the severity of the lesion. An extensive review of the subject of toxic nephropathy has been written by Schreiner and Maher (1965) . 
METHOXYFLURANE NEPHROTOXICITY
Specific anaesthetic-induced nephrotoxicity was first reported by Crandell et al. (1966) , in 13 of 41 patients anaesthetized with methoxyflurane for abdominal surgery. They noted polyuria with a negative fluid balance, elevation of serum sodium, serum osmolality and blood urea nitrogen, and fixed urine osmolality close to that of serum. Patients were unable to concentrate urine despite fluid deprivation and vasopressin administration, suggesting that the difficulty was of renal origin and not due to antidiuretic hormone (ADH) deficiency. Impairment lasted from 10-20 days in most patients, but in three, abnormalities persisted for longer than one year.
In the five years following the publication of Crandell et al. (1966) only a few case reports of high output renal insufficiency associated with methoxyflurane administration had been reported (Elkington et al. 1968 , Kuzucu 1970 , LaPointe and Belle-Binda 1970 , Lebowitz 1969 until the controlled, randomized, prospective, clinical evaluation from Mazze et al . (1971a, 1971b) .
Abnormalities were found in all cases; some patients exhibited polyuria unresponsive to ADH administration, marked weight loss, delayed return of normal urine concentrating ability, hypernatraemia, serum hyperosmolality, elevated BUN and serum creatinine, increased serum uric acid and a decrease in uric acid clearance. Nephrotoxicity was not permanent in any of these patients, however, permanent renal failure has been reported many times following methoxyflurane anaesthesia (Hollenberg et al. 1972 , Albers et al. 1971 , Panner et al. 1970 , Frascino et al. 1970 , Aufderheide 1971 .
Evidence Relating Methoxyflurane Metabolism to
Nephrotoxicity It had been suggested by Taves et al. (1970) that a metabolite of methoxyflurane, inorganic fluoride, was related to its nephrotoxicity. They reported increased concentrations of inorganic fluoride in the serum and urine of a patient who had renal dysfunction following methoxyflurane anaesthesia. About the same time, Frascino et al. (1970) noted oxalic acid crystals in renal biopsy specimens and increased urinary oxalic acid excretion in several patients with renal insufficiency following methoxyflurane anaesthesia. We subsequently reported increased concentrations of inorganic fluoride in all patients anaesthetized, with the highest levels in those patients with the greatest impairment of renal function (Mazze et al. 1971b) .
Similarly, patients with clinically-evident nephrotoxicity had a mean peak oxalic acid excretion significantly greater than patients with laboratory abnormalities only.
To explain the increased inorganic fluoride concentration and oxalic acid excretion following methoxyflurane anaesthesia we proposed two complementary metabolic routes for biotransformation of methoxyflurane (Figure 1) . These were based on our findings, other metabolites identified previously (Holaday et al. 1971) , and enzyme systems known to exist in man. Of these metabolites, both inorganic fluoride and oxalic acid have nephrotoxic potential with the former the most likely cause of polyuria (Mazze et al. 1971b) . Reproduced with permission of J. Pharm. and Exp. They. (Mazze et al. 1973a ).
This evidence suggested the renal toxicity of methoxyflurane was directly related to the dose of methoxyflurane and its metabolism to inorganic fluoride. Supporting the concept of a dose-related lesion, we found no changes in renal function in a randomized, prospective study of patients anaesthetized with small doses of methoxyflurane (2/3 MAC; anaesthesia time, . ) hours 10 minutes) for operations involving cardiopulmonary b~'pass (Cousins cl a!. 197~). ~Iean peak serum inorganic fluoride concentration was only 25-50 per cent of that previoush' found to produce renal dysfunction.
Evidence of J1ctlzoxyjluYilllC .\-eplzroloxicilv ill all
A 1/ imal J10del A direct cause-effect relationship of methoxyflurane administration and renal dysfunction was still not conclusively established, in part due to the absence of nephrotoxicit\· in animal experiments (Cale et al. 1967 , Boba 1965 , Bergeron et al. 1963 . After studying the renal effects of methox\'flurane in five rat strains, it was found that Fischer : 14.4 and Buffalo rats metabolized methoxyflurane to a greater extent than the other three strains as evidenced b\' higher s('rum and urine inorganic fluoride activit~:. However, onh' Fischer 344 rats de,-eloped functional ( Figure ~) and pathological evidence of a renal lesion (l\Iazze ct al. 1973 ). Injection of inorganic fluoride (N aF) produced a much greater degree of renal insufficiency in Fischer 344 rats than in Buffalo rats. It was concluded that there was variation in the rate of metabolism of methoxyflurane to inorganic fluoride and in its nephrotoxic effects among various rat strains. A high rate of methoxyflurane metabolism and increased susceptibility to the nephrotoxic effects of inorganic fluoride resulted in polyuric renal insufficienn' in Fischer 344 rats. Subsequent studies In this animal model (Mazze et al. , Kosek et al. 1972 ) showed that, as in man, the renal functional and pathological changes were proportional to the dose of methoxyflurane (Figures 3 and ·1) . Polyuria was vasopressin resistant whether re~ulting from methox\-flurane anaesthesia or from direct injection or inorganic fluoridE' (Figure ; and animals (Mazze et , Kosek et al. 1972 ) have shown that the degree of nephrotoxicity following methoxyflurane anaesthesia is proportional to the amount of metabolite produced from biotransformation of the drug. The following evidence points to inorganic fluoride rather than oxalic acid as the primary nephrotoxic metabolite: (1) The production in an animal model of dose-related polyuric renal insufficiency and pathological abnormalities following sodium fluoride injection, similar to those found after methoxyflurane anaesthesia (Mazze et al. 1972 );
(2) The inability to produce acute abnormalities in renal function FIGURE 4A.-Electron micrograph x 4,000 of proximal convoluted tubular cell from unanaesthetized control rat. Note the predominance of normally long and thin mitochondria (m). Also identified are nucleus (n), basement membrane (bm), and a few scattered dense bodies (db).
in rats following injection of oxalic acid in doses similar to those resulting from methoxyflurane anaesthesia (Cousins and Mazze 1973c) ; (3) The fact that acute oxalic acid intoxication results in classical anuric renal failure and elevation in oxalic acid excretion is associated with kidney stone formation (Hockaday et al. 1964, Jeghers and Murphy 1945) and (4) The known potent inhibitory effect of inorganic fluoride on many enzyme systems, including those thought to be involved in sodium transport and ADH action (Wiseman 1970). Anaesthesia and Intensive Care, Vol. I, No. 5, August, 1973 n l\IICHAEL ]. COUSINS AND RICHARD 1. MAZZE Thus, it is unlikely that oxalic acid is of importance in the production of the acute lesion of methoxyflurane nephrotoxicity. However, it is possible that oxalic acid is a factor in the production of the chronic lesion seen in patients with permanent renal impairment. Although the number of oxalate crystals observed in kidney sections (Panner et al. 1970 , Frascino et al. 1970 , Aufderheide 1971 have been insufficient to cause significant obstruction to urine flow, they could have acted as a nidus for inflammation with subsequent scarring of the renal tubules and interstitium. OA VS POST ANESTHESIA FIGURE fiA.-T'itrcssin administr:ltion had no effect on the increase in 24 hour urine '.'olum" following administration of O·tjO~ methoxyflurane for three hours. Abbreviation: SE:'.!, standard error of nlcan.
THE SITE AND MECHANISl\I OF THE RENAL LESION
Because polyuria following methoxyflurane anaesthesia is vasopressin resistant, it was originally postulated that inorganic fluoride caused nephrotoxicity by interfering with the action of anti-diuretic hormone in the distal convoluted tubule and collecting duct (Mazze et al. 1971b) . However, animal studies (l\Iazze et al. , Kosek et al. 1972 ) showed that the major pathological lesions were in the proximal convoluted tubule with damage ranging from mitochondrial swelling to necrosis of epithelial cells. Few abnormalities were noted in the distal nephron. Thus it appears that the pathogenesis of the early pol~'uric response following methoxyflurane anaesthesia may be different from that of the more severe chronic lesion which occasionally occurs. Early functional abnormalities in man may be produced by fluoride inhibition of enzyme systems necessary for sodium pumping (Wiseman 1970) in the ascending limb of the loop of Henle or early distal tubule. This would result in decreased renal medullary hyperosmolality (Whitford and Taves, In Press), decreased reabsorption of water from the collecting ducts and polyuria. This explanation is consistent with the inability to dilute or concentrate urine, recently demonstrated in man (Cousins and Mazie 1973a) . Definitive anatomic localization of the earh' renal lesion in man has not been accomplished as biopsy specimens have not been obtained.
In patients with permanent renal failure following methoxyflurane, biopsy and autopsy specimens have demonstrated oxalate deposition, proximal tubular dilatation, and interstitial fihrosis (Kucuzu 1970 , Hollenberg et al. 1972 ?50~ Uej>roduced with permission of A nrsti!%i%gv (.1Jazze et al. 197:: Panner et al. 1970 , Halpren et al. 1973 ). The first two of these findings have been reported in animal studies following doses of methoxyflurane which caused fatal renal failure , Kosek et al. 1972 . Although it appears that oxalate crystal deposition plays little part in the pathogenesis of the acute lesion, production of a chronic lesion with overwhelming damage may be related to the combined toxic effects of high levels of inorganic fluoride and oxalic acid resulting from the metabolism of methoxyflurane.
Cs
EVIDENCE OF DOSE-RELATED NEPHROTOXICITY IN MAN
Although animal studies appeared conclusive, there was still doubt as to the nephrotoxicity of methoxyflurane in man (Editorial 1971). In part, this was due to the fact that in our initial clinical study (Mazze et al. 1971a , Mazze et al. 1971b ) methoxyflurane was administered without anaesthetic adjuvants and its dosage was not precisely defined. This raised the question of the relationship between methoxyflurane dosage and renal dysfunction when the drug is employed with anaesthetic adjuvants. It was possible also that anaesthetic adjuvants such as thiopentone might have protected the kidney against nephrotoxicity (Aprahamian 1959). Therefore a study was designed to precisely document methoxyflurane dosage in each patient and to determine the renal functional changes that occurred with increasing do,;age.
Dosage has rarely been measured in studies of inhalation anaesthetics, documentation usually consisting of estimations of depth of anaesthesia. In recent vears, numerous studies have shown that inhalation anaesthetics are not inert but are, in fact, readilv metabolized (Cohen 1971) . Thus, duration o(administration becomes as important as precise measurement of depth for determining total anaesthetic dosage. As a convenient extension of the MAC concept of anaesthetic depth (Saidman et al. 1967 ) we expressed anaesthetic dosage as "MAC hours ", i.e., MAC times duration of anaesthesia (Cousins and Mazze ] 973a).
In this randomized prospective, clinical study of general surgical patients in which anaesthetic adjuvants were administered, we correlated nephrotoxicity with methoxyflurane dosage and serum inorganic fluoride concentration (Cousins and Mazze ] 973a). Patients anaesthetized with a methoxyflurane dose of 2·0 MAC hours, or less, had peak serum inorganic fluoride concentrations below 40 fLM/I; this was not associated with nephrotoxicity. The threshold of sub-clinical toxicity occurrEd at a dosage of 2·5 to 3 MAC hours, corresponding to peak serum inorganic fluoride levels of 50-80 fLM/I ( Figure 6) . These patients had delayed return to maximum pre-operative urine osmolality, unresponsiveness to vasopressin administration and elevated serum uric acid concentration. Mild clinical toxicitv occurred at a dosage of 5 MAC hours (serum inorganic fluoride concentration 90-120 fLM/I).
In addition to the abnormalities noted above, serum hyperosmolality, hypernatraemia, polyuria and low urine osmolality were present. Finally, clinical toxicity occurred in all three patients with methoxyflurane dosage greater than 7 MAC hours (peak serum inorganic fluoride levels 80-175 fLM/l). Abnormalities in serum and urine variables were even more pronounced than at lower methoxyflurane dosages. In addition, all patients had thirst and polyuria which added difficulty to their clinical management. et al. 1971b , Taves et al. 1970 ) are shown for comparison. Abhreviation: CPI3, cardiopulmonary bypass.
A significant permanent reduction in creatinine clearance was seen only in one patient who received 9 MAC hours of methoxyflurane and required a course of gentamicin for a postoperative Psuedomonas wound infection. His creatinine clearance was reduced from 107 mll min prior to gentamicin treatment to 40 ml/min after four days of antibiotic therapy (Mazze and Cousins 1973a) (Figure 7) . We have subsequently shown in an animal model that the adverse renal functional and pathological effects of gentamicin and methoxyflurane are additive (Figure 8) . Initial studies indicate that the toxicity of methoxyflurane is also increased by concurrent treatment with tetracycline Mazze 1973c, Proctor and Barton 1971) and other potentially nephrotoxic drugs.
at an inorganic fluoride level of 100 [LMjl; this level developed after 2·5 MAC hours, a relatively low methoxyflurane dose. He had been taking pentobarbital chronically until three days prior to anaesthesia. It is likely the high serum inorganic fluoride levels which occurred in this ...... .;1 .___-- Reproduced with permission of Brit. J. Anaesth. (."vfazze and Cousins I973a) .
Superimposed on the dose-response relationship were individual variations in methoxyflurane metabolism and renal sensiti\"ity to inorganic fluoride: (1) One patient anaesthetized with 9 MAC hours of methoxyflurane developed clinical nephrotoxicity, however, his peak serum inorganic fluoride level, 80 [LMjl was much lower than expected for this methoxyflurane dose. He appeared to metabolize methoxyflurane to inorganic fluoride only minimally, but was unusually sensitive to its nephrotoxic effects.
(2) Another patient had signs of nephrotoxicity patient were due to induction of hepatic drug metabolizing enzyme systems. Studies in rats support these findings: (1) Strain differences in the metabolism of methoxyflurane and susceptibility to the nephrotoxic effects of inorganic fluoride ) were similar to the individual differences reported in man.
(2) Enzyme induction with phenobarbital in rats prior to low dose methoxyflurane resulted in greater serum inorganic fluoride levels and more severe nephrotoxicity than methoxyflurane treatment alone ).
Anaesthesia and Intensive Care. Vol. 1, No. 5, August, 1973 Reproduced with permission of Brit. J. A naes/h. ).
SUMMARY OF FACTORS IN THE PRODUCTION OF METHOXYFLURANE NEPHROTOXICITY
The predominant factor appears to be methoxyflurane dosage and serum inorganic fluoride concentration.
Secondary factors may be: (1) A high rate of methoxyflurane metabolism and sensitivity of the kidney to inorganic fluoride toxicity.
(2) Concurrent treatment with other nephrotoxic drugs: (a) Nephrotoxic Antibiotics: Sulphonamides, gentamicin, tetracycline, neomycin, polymixin B, colistin, kanamycin, bacitracin, streptomycin and amphotericin B (Schreiner 1972) . There have been several recent reports which have concluded that methoxyflurane administration does not result in nephrotoxicity. The apparent conflict of results may be due to errors in design and/or analysis of data. When doserelated toxicity is investigated a sine qua non is the precise measurement of anaesthetic dosage. Statistical analysis should attempt to correlate changes in renal function variables with anaesthetic dosage. Also, there should be a sufficient spread of dosage to determine a dose-response relationship. For example in the study of Oyama and Kimura (1972) neither dosage nor serum inorganic fluoride level was measured. In addition, data was analysed by pooled means. Our analysis of their data suggests abnormalities occurred in a few patients at higher dosage, which were probably obscured by the majority of patients at low dosage. A study of " light " methoxyflurane anaesthesia by Hetrick et al. (1973) also did not detect any abnormalities in renal function. Once again pooled means were used and the maximum duration of methoxyflurane anaesthesia was 145 minutes giving a probable maximum dose of 1·5 to 2·5 MAC hours. This study, in fact, is in perfect agreement with our own studies of low dose methoxvflurane anaesthesia. Sensitive tests of ren-al function such as pitressin infusion are necessary to detect abnormalities in renal function at methoxyflurane doses as low as 2 to 2·5 MAC hours. From our analysis of these reports it appears misleading to conclude that nephrotoxicity only results from "over-dosage of methoxyflurane". A nephrotoxic dose of methoxyflurane may be delivered even if very light anaesthesia (0' 7 MAC) is maintained for 4-5 hours or after 2-3 hours at deeper methoxyflurane levels.
The subclinical toxicity occurring at 2·5 to 3 MAC hours is probably not significant in most circumstances. However, this degree of toxicity assumes importance in patients with pre-existing renal disease or in patients concurrently exposed to other nephrotoxic drugs.
CLINICAL IMPLICATIONS
All of the above factors must be considered in attempting to answer the question: What is the safety margin between the clinically useful and nephrotoxic doses of methoxyflurane? A meth-:\IrCHAEL J. COl;SINS AND RICHARD I. MAZZE oxyflurane dose of :! ·.')~;{·O MAC hours usually results in subclinical toxicity with clinical signs not appearing until a dose of 5·0 MAC hours. However, we believe a dose of 2 ·0~2·5 MAC hours should not be exceeded in order to avoid clinical nephrotoxicity due to the superimposition of the factors other than dosage, noted above. Surgical anaesthesia can theoretically be maintained at a depth of less than one }IAC by using supplementary nitrous oxide, narcotics and muscle relaxants; however, in the usual clinical setting blood and alveolar anaesthetic concentrations are not routinely measured, so that the anaesthetist can never be certain of exact anaesthetic concentration. Therefore, the most practical \\'a~' to remain below a dose of (Table 2) should not receIve methoxyflurane nor should patients taking enzyme-inducing or nephrotoxic drugs. The postoperative requirement for nephrotoxic antibiotics is difficult to predict, but it is presumed to be more likely when surgical procedures are extensive.
When considering administration of methoxyflurane the indications for its use should he carefully assessed in light of its potential for nephrotoxicity. Specifically, it should be restricted to situations where low dosage can he attained, such as obstetric analgesia and anaesthesia, open-heart surgery when operative time is not prolonged* and other surgical procedures of less than two hours duration. If the procedure unexpectedly continues beyond this time, methoxyflurane administration should be discontinued and the procedure completed with alternative techniques such as narcotics, nitrous oxide and muscle relaxants. Knowledge of the factors involved in production of methoxyflurane nephrotoxicit~, and application of the dosage Values for the unanaesthetized control group for the same period, arc shown for comparison. Both methoxyflurane and isofluranc treated rats hac! significant increases in serum inorganic fluoride concentration; however, the changes were mUC,l greater in thc methoxyflurane groups.
restrictions outlined above is essential if this agent is to be administered safely in clinical anaesthetic practice.
OTHER FLUORINATED ANAESTHETICS AND N EPHROTO XICITY
Evidence of the nephrotoxic potential of inorganic fluoride has prompted the examination of other fluorinated anaesthetics to determine their ease of defluorination (Cousins and Mazze 1973b) . Molecular orbital calculations by Loew et al. (1973) predicted the degree of defluorination would be in the order methoxyflurane>enflurane > isoflurane > halothane. Our animal (Mazze et al. 1972a , Cousins et al. 1973b ) and clinical studies (Mazze et al. 1971b, Cousins and have confirmed this order. Halothane is metabolized to inorganic fluoride to a negligible extent; serum inorganic fluoride levels do not increase above pre-anaesthetic values. Isoflurane is significantly metabolized to inorganic fluoride but serum levels have not exceeded 20 fLMfl in man or animals. Animal and (Cousins et al. 1973b). clinical studies with both of these agents have revealed no renal abnormalities at doses comparable to nephrotoxic doses of methoxyflurane (Cousins et al. 1973b , Mazze et al. 1973c ) ( Figure  9 ). Enflurane is metabolized to a greater extent than isoflurane with serum fluoride levels as high as 38 fLMfl measured in man (Chase et al. 1971, Cousins and Mazze 1973c) .
No renal abnormalities have been reported to date, however, the possibility of nephrotoxicity in patients taking enzyme-inducing or nephrotoxic drugs requires investigation ).
NEW CONCEPTS OF INTRAOPERATIVE FLUID AND ELECTROLYTE HOMEOSTASIS
" Surgical Renal Failure" may be described as the persistence of the usually transient intraoperative changes in renal function, such that the kidneys are not able to vary urine volume and content appropriately in response to homeostatic needs. Except in the case of methoxyflurane, renal failure is probably never due to the choice of anaesthetic agent alone; rather, it is more likely due to a combination of surgical and anaesthetic factors. Since surgical renal failure is really a syndrome occurring in the postoperative period rather than a specific disease entity the patient's clinical condition may vary from mild impairment of renal function to anuria.
The pathophysiology of acute renal failure is still uncertain but present concepts favour reduced RBF and selective reduction of renal cortical blood flow (Hollenberg et al. 1968 ) together with a reduction in individual nephron and overall GFR (Oken et al. 1966) . It has been claimed that preoperative and intraoperative measures to prevent intra-renal vasoconstriction, such as adequate hydration, significantly lower the incidence of surgical oliguria (Barry et al. 1964 ). However, it is probable that reduced renal cortical blood flow is secondary to elevated catecholamine and renin-angiotensin levels during surgery and anaesthesia (Truniger 1971) . The effects of administration of salt solutions on renal vasoconstriction have not been assessed. I t should be emphasized that this neuroendocrine response to trauma and surgery may be wellestablished in acute trauma and other cases with " critical reduction" in circulating volume (Barry et al. 1964) . In these instances it is possible that subsequent infusions of large volumes of crystalloid will onl y serve to overload the circulation.
Nevertheless, a concept has evolved which serves as a working hypothesis for the clinical approach to fluid therapy prior to and during surgery. Hayes et al. (1957 Hayes et al. ( , 1959 demonstrated that both the antidiuresis and sodium retention in patients having major surgery could be reduced by infusing a litre or more of Ringer's lactate solution 8-12 hours preoperatively and continuing the administration of sodiumcontaining fluids throughout the postoperative period. It was their opinion that postoperative sodium intolerance was due, at least in part, to preoperative and intraoperative sodium restriction. Shires et al. (1961 measured body fluid compartments b\~ isotope techniques and supported Haves' conclusions. Thev found reductions of up to 2fl per cent in the extracellular space which correlated with the degree of surgical trauma. They postulated the formation of a third space not in ready communication with more mobile, and functionally significant, interstitial fluid volume. To replace third space loss, recommended infusion of 500-1000 ml/hour of Ringer's lactate solution during operation, up to a total of 4 litres, to prevent contraction of the functional extracellular volume, which in turn supported the intravascular volume. Using this regimen, he noted a marked reduction in sodium retention which he attributed to decreased aldosterone secretion.
Shires' position was challenged by Roth et al. (1969) who were not able to demonstrate significant deficits in extracellular fluid volume using similar isotopic techniques to those employed by Shires. They noted a deficit in extracellular fluid of only 5·7 per cent in animals subjected to 1·5 hours of profound haemorrhagic shock, whereas in similar experiments, Shires et al.
(1964) had reported as much as 43 per cent deficit in extracellular fluid.
In rebuttal, Middleton, Mathews and Shires (1969) have reproduced their earlier studies; it is likely that this debate will not be resolved.
It does appear from clinical studies of urine volume (Fieber 1967, Thompson et al. 1968 ) and renal function (Mazze and Barry 1967 , Barry et al. 1964 ) that sodium containing fluids do help to maintain renal homeostatis and clinicians now administer some salt solution during surgery, with the volume infused related to the degree of trauma. An upper limit of 3-4 litres is probably advisable to avoid the possibility of pulmonary oedema or frank congestive heart failure (Moore and Shires 1967).
The most practical contributions the anaesthetist can make are use of an anaesthetic technique and fluid regimen which mmlmlze renal functional depression, recognition of " at risk" patients (Table 2) and early detection of incipient renal failure. The diagnosis of incipient acute renal failure is made when urine flow remains below 20 ml per hour in a patient who is adequately hydrated, has stable blood pressure, and has a patent urinary outflow tract. In " at risk" patients the importance of urine output as a vital sign is equal to that of pulse rate, respiratory rate or blood pressure. An indwelling urethral catheter should be inserted prior to surgery and hourly urine volume should be measured. Correction of fluid volume losses should be carried out with appropriate crystalloid and colloid solutions including blood. Prior to induction of anaesthesia, a fluid load of Ringer's lactate or similar solution equal in volume to 10 ml/kg of body weight should be infused. This should be followed each hour by intraoperative infusion of maintenance fluids equal in volume to 5 ml/kg of body weight up to a maximum volume of 3000 m1. If urine output is less than 75-100 ml/hr with this regimen then intravenous mannitol, 12 ·5-20 grammes, should be administered within a five minute period. If the initial response to this therapy is positive but urine output decreases again, then a 5-10 per cent mannitol drip should be started and infused at a rate necessary to maintain urine flow at 75-100 ml/hr (Mazz"e and Barry 1964) . The danger of circulatory overload can be minimized by frequent auscultation of the chest and monitoring central venous pressure. If there is no response or only a partial response to fluid and mannitol therapy then the clinical situation must be re-evaluated. Frusemide, 20-40 mg administered intravenously may sometimes be of value; in some cases 2-3 doses may be necessary before a response occurs.
It is important to continue vigilance into the postoperative period in " at risk" patients, this category also including patients who inadvertently receive a high dose of methoxyflurane or concomitantly receive other nephrotoxic drugs. Measurements of serum and urine osmolality and electrolytes, weighing the patient and meticulous fluid-electrolyte balance should be carried out.
Use of light anaesthesia and an adequate fluid regimen intraoperatively usually ensures that even patients with renal impairment will have only minimal and transient depression of renal function. However" at risk" patients may sustain more profound and permanent depression of renal function both intra-and postoperatively.
Their anaesthetic manage-ment and fluid regimen may require careful selection of anaesthetic technique and monitoring of the cardiovascular and renal response to the fluid regimen chosen. It is clear that methoxyflurane should not be administered to these patients. Anaesthetic techniques using drugs with mild Cl-blocking properties may cause the least depression of renal function.
